Sustained response to lenvatinib and pembrolizumab in two patients with KRAS-mutated endometrial mesonephric-like adenocarcinoma

Mesonephric-Like Adenocarcinoma of the Endometrium: Diagnostic Advances to Spot This Wolf in Sheep’s Clothing. A Review of the Literature

(2021) Ellen Deolet et al.   Journal of Clinical Medicine

Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases

(2021) Edaise M. da Silva et al.   MODERN PATHOLOGY

Mesonephric-like adenocarcinomas of the uterine corpus: report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma

(2020) Lars-Christian Horn et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors

(2020) Matthew H. Taylor et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinicopathological study of organ metastasis in endometrial cancer

(2020) Weipu Mao et al.   Future Oncology

Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer

(2020) Vicky Makker et al.   JOURNAL OF CLINICAL ONCOLOGY

Comprehensive genomic profiling of recurrent endometrial cancer: Implications for selection of systemic therapy

(2019) Emily N. Prendergast et al.   GYNECOLOGIC ONCOLOGY

Mesonephric-like Carcinoma of the Endometrium

(2019) Elizabeth D. Euscher et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

1044PPembrolizumab in patients with MSI-H advanced endometrial cancer from the KEYNOTE-158 study

(2019) D O'Malley et al.   ANNALS OF ONCOLOGY

Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract

(2018) Jelena Mirkovic et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract

(2018) Jennifer Pors et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

A Combined Morphologic and Molecular Approach to Retrospectively Identify KRAS-Mutated Mesonephric-like Adenocarcinomas of the Endometrium

(2018) David L. Kolin et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

A phase II trial of the multitargeted kinase inhibitor E7080 in advanced radioiodine (RAI)-refractory differentiated thyroid cancer (DTC).

(2017) S. I. Sherman et al.   JOURNAL OF CLINICAL ONCOLOGY

Lenvatinib mesilate (LEN) enhanced antitumor activity of a PD-1 blockade agent by potentiating Th1 immune response

(2016) Y. Kato et al.   ANNALS OF ONCOLOGY

Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas

(2016) Marie McFarland et al.   HISTOPATHOLOGY